Clinical Trial Manufacturing
Micro-Dosing Xcelodose ® Technology
Delivering drug directly into capsules or vials using micro-dosing technology removes the need for initial formulation development and associated stability, leading to faster first-in-human studies and ultimately both time and cost efficiencies. The fully programmable system ensures exceptional levels of accuracy and precision whilst minimizing wastage of drug substance. We are proud to offer multiple options of micro-dosing technology, delivering individual client volume requirements. PCI has further invested in Xcelohood™ and Xceloprotect™ technology for the micro-dosing technologies, further enhancing our contained solutions for the development and manufacturing of highly potent drug products.
PCI provides a comprehensive service at each stage of the product lifecycle for a wide range of dosage forms in full compliance with GMP regulatory standards for both highly potent, non-potent and injectable drug products. Our strength lies in the integrated nature of our services, combining formulation and analytical development with GMP clinical manufacturing and packaging, managed by a full cross functional project team, coordinated by an experienced team of project managers. Utilizing our state-of-the-art facilities, we offer unrivaled capabilities and a true focus on customer needs. We provide clinical manufacturing of multiple dosage forms for investigational use including solid oral dose, liquids, semi-solids and aseptic fill finish processing. All clinical manufacturing and packaging services are fully supported by a dedicated and experienced team of Qualified Persons, a full analytical laboratory and a GMP compliant warehouse.
9
Together, delivering life changing therapies.
PCI Pharma Services
8
Powered by FlippingBook